{"id":55,"date":"2020-04-20T14:17:17","date_gmt":"2020-04-20T14:17:17","guid":{"rendered":"https:\/\/live-rawf.pantheonsite.io\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/"},"modified":"2023-08-01T19:28:40","modified_gmt":"2023-08-01T19:28:40","slug":"2020-4-20-manejo-de-pacientes-con-hipopituitarismo-durante-covid-19","status":"publish","type":"post","link":"https:\/\/www.rawoodfoundation.org\/es\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/","title":{"rendered":"Manejo de pacientes con hipopituitarismo durante la COVID-19"},"content":{"rendered":"<div\n        class=\"image-block-outer-wrapper          layout-caption-below          design-layout-inline          combination-animation-none          individual-animation-none          individual-text-animation-none\"\n        data-test=\"image-block-inline-outer-wrapper\"\n    ><\/p>\n<figure\n            class=\"sqs-block-image-figure              intrinsic\"\n            style=\"max-width:288px;\"\n        ><\/p>\n<div\n\n\n              class=\"image-block-wrapper\"\n              data-animation-role=\"image\"\n\n\n\n          ><\/p>\n<div class=\"sqs-image-shape-container-element              has-aspect-ratio\" style=\"                position: relative;                  padding-bottom:100%;                overflow: hidden;-webkit-mask-image: -webkit-radial-gradient(white, black);              \"\n              ><\/p>\n<p>                  <noscript><img decoding=\"async\" src=\"https:\/\/images.squarespace-cdn.com\/content\/v1\/587bc3d946c3c4be42a60e48\/1587392158652-8F77X9G2BOODRNA9IAKR\/patient-fever.jpg\" alt=\"paciente-fiebre.jpg\" \/><\/noscript><img decoding=\"async\" class=\"thumb-image\" src=\"https:\/\/images.squarespace-cdn.com\/content\/v1\/587bc3d946c3c4be42a60e48\/1587392158652-8F77X9G2BOODRNA9IAKR\/patient-fever.jpg\" data-image=\"https:\/\/images.squarespace-cdn.com\/content\/v1\/587bc3d946c3c4be42a60e48\/1587392158652-8F77X9G2BOODRNA9IAKR\/patient-fever.jpg\" data-image-dimensions=\"288x288\" data-image-focal-point=\"0.5,0.5\" alt=\"paciente-fiebre.jpg\" data-load=\"false\" data-image-id=\"5e9dae9ec8159d101875aeaf\" data-type=\"image\" \/><\/p><\/div>\n<\/p><\/div>\n<\/figure><\/div>\n<div class=\"sqs-html-content\">\n<p class=\"\" style=\"white-space:pre-wrap;\">La mayor\u00eda de los pacientes con tumores cerebrales hipot\u00e1lamo-hipofisarios padecen insuficiencia suprarrenal secundaria (IAS), que es la incapacidad del cerebro para indicar la producci\u00f3n de cortisol en caso de que el organismo se encuentre en peligro, y diabetes ins\u00edpida (DI), que es el resultado de la interrupci\u00f3n de la producci\u00f3n de la hormona antidiur\u00e9tica que provoca problemas con el equilibrio de los l\u00edquidos corporales y los niveles de sodio en sangre. Con el brote de coronavirus, han surgido muchas preguntas sobre si los pacientes con SAI est\u00e1n inmunodeprimidos o son de \"alto riesgo\". <\/p>\n<p class=\"\" style=\"white-space:pre-wrap;\">Recientemente se han publicado algunos art\u00edculos sobre este tema. <a href=\"https:\/\/academic.oup.com\/jcem\/article\/105\/5\/dgaa148\/5814115\" target=\"_blank\" rel=\"noopener\">El Journal of Clinical Endocrinology &amp; Metabolism (JCEM) public\u00f3 un art\u00edculo en l\u00ednea<\/a> hace unas semanas para el n\u00famero de mayo de 2020 que destaca algunas directrices a tener en cuenta para los pacientes con SAI y DI. He aqu\u00ed algunos puntos clave: <\/p>\n<h2 style=\"white-space:pre-wrap;\">Dosis de mantenimiento <\/h2>\n<p class=\"\" style=\"white-space:pre-wrap;\">Los pacientes deben continuar con su dosis diaria de mantenimiento de esteroides. Aunque el uso de esteroides puede poner a los pacientes en la categor\u00eda de alto riesgo COVID-19, no tomar la dosis diaria de mantenimiento pone al paciente en mayor riesgo de una crisis suprarrenal. <\/p>\n<h2 style=\"white-space:pre-wrap;\">Dosis de estr\u00e9s <\/h2>\n<p class=\"\" style=\"white-space:pre-wrap;\">Los pacientes deben revisar las \"reglas de los d\u00edas de enfermedad\" con los m\u00e9dicos. En caso de s\u00edntomas de COVID-19 -es decir, tos seca y fiebre- puede ser necesaria una dosis de estr\u00e9s. S\u00f3lo se debe administrar una dosis de estr\u00e9s en caso de s\u00edntomas, no para prevenirlos. Si las condiciones del paciente empeoran y experimenta v\u00f3mitos o diarrea, busque atenci\u00f3n m\u00e9dica urgente. <\/p>\n<h2 style=\"white-space:pre-wrap;\">Esteroides y COVID-19 <\/h2>\n<p class=\"\" style=\"white-space:pre-wrap;\">La Organizaci\u00f3n Mundial de la Salud (OMS) ha indicado que los corticoides no son un tratamiento para la COVID-19. Seg\u00fan el JCEM, en caso de enfermedad y hospitalizaci\u00f3n, los m\u00e9dicos tratantes deben administrar hidrocortisona en dosis de estr\u00e9s por v\u00eda intravenosa. <\/p>\n<h2 style=\"white-space:pre-wrap;\">Enfermedad y diabetes ins\u00edpida <\/h2>\n<p class=\"\" style=\"white-space:pre-wrap;\">Las enfermedades y las dosis de estr\u00e9s con esteroides tambi\u00e9n pueden influir en la gesti\u00f3n de l\u00edquidos. Seg\u00fan el JCEM, es importante vigilar cuidadosamente las entradas y salidas y tener en cuenta las p\u00e9rdidas insensibles debidas a la fiebre para evitar desequilibrios de sodio, sobre todo si el paciente est\u00e1 inconsciente debido a una enfermedad. <\/p>\n<h2 style=\"white-space:pre-wrap;\">Preparativos para una hospitalizaci\u00f3n <\/h2>\n<p class=\"\" style=\"white-space:pre-wrap;\">Dado que los pacientes con EFS o DI pueden tener que ser hospitalizados de vez en cuando fuera de una crisis sanitaria global, es aconsejable consultar regularmente con el hospital que le atiende para estar al tanto de las directrices vigentes para las visitas hospitalarias y de cualquier otro cambio de pol\u00edtica que pueda afectarle. Tenga una carta de emergencia actualizada de su endocrin\u00f3logo para presentarla a su llegada al hospital. Si no tiene una carta, tambi\u00e9n es \u00fatil una documentaci\u00f3n concisa de su historial m\u00e9dico. <\/p>\n<h2 style=\"white-space:pre-wrap;\">Conclusi\u00f3n<\/h2>\n<p class=\"\" style=\"white-space:pre-wrap;\">Esperamos que esto ayude a comprender mejor la informaci\u00f3n disponible sobre estas afecciones en relaci\u00f3n con el COVID-19. Lo mejor es seguir manteniendo las directrices de los CDC de practicar el distanciamiento social, quedarse en casa cuando sea posible y usar una m\u00e1scara para evitar la propagaci\u00f3n para mantenerse saludable y mantenerse a s\u00ed mismo ya otros seguros. <\/p>\n<h2 style=\"white-space:pre-wrap;\">Fuentes<\/h2>\n<p class=\"\" style=\"white-space:pre-wrap;\"><a href=\"https:\/\/academic.oup.com\/jcem\/article\/105\/5\/dgaa148\/5814115\" target=\"_blank\" rel=\"noopener\">Nuestra respuesta a COVID-19 como endocrin\u00f3logos y diabet\u00f3logos<\/a><em><br \/><\/em>Ursula B Kaiser, Raghavendra G Mirmira, Paul M Stewart<br \/>Revista de Endocrinolog\u00eda Cl\u00ednica y Metabolismo<\/p>\n<p class=\"\" style=\"white-space:pre-wrap;\"><a href=\"https:\/\/www.health.harvard.edu\/diseases-and-conditions\/if-you-are-at-higher-risk\" target=\"_blank\" rel=\"noopener\">Si corre mayor riesgo: c\u00f3mo reducir el riesgo de infecci\u00f3n y qu\u00e9 hacer si enferma<\/a><br \/>Harvard Health Publishing<\/p>\n<p class=\"\" style=\"white-space:pre-wrap;\"><a href=\"https:\/\/www.medicalnewstoday.com\/articles\/managing-patients-with-endocrine-dysfunction-during-covid-19\" target=\"_blank\" rel=\"noopener\">Manejo de pacientes con disfunci\u00f3n endocrina durante COVID-19<\/a><br \/>Noticias m\u00e9dicas de hoy<\/p>\n<p class=\"\" style=\"white-space:pre-wrap;\"><a href=\"https:\/\/health.usnews.com\/health-care\/for-better\/articles\/coronavirus-and-endocrine-disease\" target=\"_blank\" rel=\"noopener\">Qu\u00e9 debe saber si padece una enfermedad endocrina durante la pandemia de coronavirus<\/a><br \/>U.S. News &amp; World Report<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p class=\"\">La mayor\u00eda de los pacientes con tumores cerebrales hipot\u00e1lamo-hipofisarios padecen insuficiencia suprarrenal secundaria (IAS), que es la incapacidad del cerebro para indicar la producci\u00f3n de cortisol en caso de que el organismo se encuentre en peligro, y diabetes ins\u00edpida (DI), que es el resultado de la interrupci\u00f3n de la producci\u00f3n de la hormona antidiur\u00e9tica que provoca problemas con el equilibrio de los l\u00edquidos corporales y los niveles de sodio en sangre. Con el brote de coronavirus, han surgido muchas preguntas sobre si los pacientes con SAI est\u00e1n inmunodeprimidos o son de \"alto riesgo\".<\/p>","protected":false},"author":6,"featured_media":56,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[42,1],"tags":[],"class_list":["post-55","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-medical","category-uncategorized","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33","no-featured-image-padding"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Managing Hypopituitarism Patients During COVID-19 - Raymond A. Wood Foundation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rawoodfoundation.org\/es\/2020\/04\/20\/2020-4-20-manejo-de-pacientes-con-hipopituitarismo-durante-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Managing Hypopituitarism Patients During COVID-19 - Raymond A. Wood Foundation\" \/>\n<meta property=\"og:description\" content=\"Most hypothalamic-pituitary brain tumor patients suffer from secondary adrenal insufficiency (SAI), which is the brain\u2019s inability to signal cortisol production in the event of the body being in distress, and diabetes insipidus (DI), the which is a result of the disruption of production of the anti-diuretic hormone which causes issues with body fluid balances and blood sodium levels. With the coronavirus outbreak, many questions have been raised about patients with SAI being immunosuppressed or \u201chigh-risk.\u201d\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rawoodfoundation.org\/es\/2020\/04\/20\/2020-4-20-manejo-de-pacientes-con-hipopituitarismo-durante-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Raymond A. Wood Foundation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rawoodfoundation\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-20T14:17:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-01T19:28:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2020\/04\/patient-fever.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"288\" \/>\n\t<meta property=\"og:image:height\" content=\"288\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"RAWF\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@rawoodfound\" \/>\n<meta name=\"twitter:site\" content=\"@rawoodfound\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"RAWF\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/\"},\"author\":{\"name\":\"RAWF\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#\\\/schema\\\/person\\\/12e3ee04f1646efc9cbbc13eb127f3b4\"},\"headline\":\"Managing Hypopituitarism Patients During COVID-19\",\"datePublished\":\"2020-04-20T14:17:17+00:00\",\"dateModified\":\"2023-08-01T19:28:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/\"},\"wordCount\":531,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/patient-fever.jpg\",\"articleSection\":[\"Health &amp; Medical\",\"Uncategorized\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/\",\"name\":\"Managing Hypopituitarism Patients During COVID-19 - Raymond A. Wood Foundation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/patient-fever.jpg\",\"datePublished\":\"2020-04-20T14:17:17+00:00\",\"dateModified\":\"2023-08-01T19:28:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/patient-fever.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/patient-fever.jpg\",\"width\":288,\"height\":288,\"caption\":\"exc-5e9daac156774a007c2d3154\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/2020\\\/04\\\/20\\\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Managing Hypopituitarism Patients During COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#website\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/\",\"name\":\"Raymond A. Wood Foundation\",\"description\":\"The mission of the RAWF is to provide quality of life support for childhood brain tumor survivors and their families.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#organization\",\"name\":\"Raymond A. Wood Foundation\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Raymond-A-Wood-Foundation-logo.webp\",\"contentUrl\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Raymond-A-Wood-Foundation-logo.webp\",\"width\":470,\"height\":128,\"caption\":\"Raymond A. Wood Foundation\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rawoodfoundation\",\"https:\\\/\\\/x.com\\\/rawoodfound\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/#\\\/schema\\\/person\\\/12e3ee04f1646efc9cbbc13eb127f3b4\",\"name\":\"RAWF\",\"url\":\"https:\\\/\\\/www.rawoodfoundation.org\\\/es\\\/author\\\/rawf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Manejo de pacientes con hipopituitarismo durante la COVID-19 - Raymond A. Wood Foundation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rawoodfoundation.org\/es\/2020\/04\/20\/2020-4-20-manejo-de-pacientes-con-hipopituitarismo-durante-covid-19\/","og_locale":"es_MX","og_type":"article","og_title":"Managing Hypopituitarism Patients During COVID-19 - Raymond A. Wood Foundation","og_description":"Most hypothalamic-pituitary brain tumor patients suffer from secondary adrenal insufficiency (SAI), which is the brain\u2019s inability to signal cortisol production in the event of the body being in distress, and diabetes insipidus (DI), the which is a result of the disruption of production of the anti-diuretic hormone which causes issues with body fluid balances and blood sodium levels. With the coronavirus outbreak, many questions have been raised about patients with SAI being immunosuppressed or \u201chigh-risk.\u201d","og_url":"https:\/\/www.rawoodfoundation.org\/es\/2020\/04\/20\/2020-4-20-manejo-de-pacientes-con-hipopituitarismo-durante-covid-19\/","og_site_name":"Raymond A. Wood Foundation","article_publisher":"https:\/\/www.facebook.com\/rawoodfoundation","article_published_time":"2020-04-20T14:17:17+00:00","article_modified_time":"2023-08-01T19:28:40+00:00","og_image":[{"width":288,"height":288,"url":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2020\/04\/patient-fever.jpg","type":"image\/jpeg"}],"author":"RAWF","twitter_card":"summary_large_image","twitter_creator":"@rawoodfound","twitter_site":"@rawoodfound","twitter_misc":{"Escrito por":"RAWF","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/#article","isPartOf":{"@id":"https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/"},"author":{"name":"RAWF","@id":"https:\/\/www.rawoodfoundation.org\/#\/schema\/person\/12e3ee04f1646efc9cbbc13eb127f3b4"},"headline":"Managing Hypopituitarism Patients During COVID-19","datePublished":"2020-04-20T14:17:17+00:00","dateModified":"2023-08-01T19:28:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/"},"wordCount":531,"publisher":{"@id":"https:\/\/www.rawoodfoundation.org\/#organization"},"image":{"@id":"https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2020\/04\/patient-fever.jpg","articleSection":["Health &amp; Medical","Uncategorized"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/","url":"https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/","name":"Manejo de pacientes con hipopituitarismo durante la COVID-19 - Raymond A. Wood Foundation","isPartOf":{"@id":"https:\/\/www.rawoodfoundation.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2020\/04\/patient-fever.jpg","datePublished":"2020-04-20T14:17:17+00:00","dateModified":"2023-08-01T19:28:40+00:00","breadcrumb":{"@id":"https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/#primaryimage","url":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2020\/04\/patient-fever.jpg","contentUrl":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2020\/04\/patient-fever.jpg","width":288,"height":288,"caption":"exc-5e9daac156774a007c2d3154"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rawoodfoundation.org\/2020\/04\/20\/2020-4-20-managing-hypopituitarism-patients-during-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rawoodfoundation.org\/"},{"@type":"ListItem","position":2,"name":"Managing Hypopituitarism Patients During COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.rawoodfoundation.org\/#website","url":"https:\/\/www.rawoodfoundation.org\/","name":"Fundaci\u00f3n Raymond A. Wood","description":"La misi\u00f3n de la RAWF es proporcionar apoyo a la calidad de vida de los supervivientes de tumores cerebrales infantiles y sus familias.","publisher":{"@id":"https:\/\/www.rawoodfoundation.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rawoodfoundation.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.rawoodfoundation.org\/#organization","name":"Fundaci\u00f3n Raymond A. Wood","url":"https:\/\/www.rawoodfoundation.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.rawoodfoundation.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2023\/07\/Raymond-A-Wood-Foundation-logo.webp","contentUrl":"https:\/\/www.rawoodfoundation.org\/wp-content\/uploads\/2023\/07\/Raymond-A-Wood-Foundation-logo.webp","width":470,"height":128,"caption":"Raymond A. Wood Foundation"},"image":{"@id":"https:\/\/www.rawoodfoundation.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rawoodfoundation","https:\/\/x.com\/rawoodfound"]},{"@type":"Person","@id":"https:\/\/www.rawoodfoundation.org\/#\/schema\/person\/12e3ee04f1646efc9cbbc13eb127f3b4","name":"RAWF","url":"https:\/\/www.rawoodfoundation.org\/es\/author\/rawf\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rawoodfoundation.org\/es\/wp-json\/wp\/v2\/posts\/55","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rawoodfoundation.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rawoodfoundation.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rawoodfoundation.org\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rawoodfoundation.org\/es\/wp-json\/wp\/v2\/comments?post=55"}],"version-history":[{"count":1,"href":"https:\/\/www.rawoodfoundation.org\/es\/wp-json\/wp\/v2\/posts\/55\/revisions"}],"predecessor-version":[{"id":8034,"href":"https:\/\/www.rawoodfoundation.org\/es\/wp-json\/wp\/v2\/posts\/55\/revisions\/8034"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rawoodfoundation.org\/es\/wp-json\/wp\/v2\/media\/56"}],"wp:attachment":[{"href":"https:\/\/www.rawoodfoundation.org\/es\/wp-json\/wp\/v2\/media?parent=55"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rawoodfoundation.org\/es\/wp-json\/wp\/v2\/categories?post=55"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rawoodfoundation.org\/es\/wp-json\/wp\/v2\/tags?post=55"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}